CSPC Pharmaceutical’s goserelin sustained-release injection approved for China trial
CSPC Pharmaceutical Group says its goserelin sustained-release injection has received clinical trial approval in China.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.